ID   BRWD3_HUMAN             Reviewed;        1802 AA.
AC   Q6RI45; C9IZ39; C9J3F3; Q2T9J6; Q5JRN1; Q6RI37; Q6RI42; Q6RI44; Q8N916;
DT   03-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 2.
DT   28-JUN-2023, entry version 152.
DE   RecName: Full=Bromodomain and WD repeat-containing protein 3;
GN   Name=BRWD3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4), TISSUE SPECIFICITY,
RP   CHROMOSOMAL TRANSLOCATION WITH ARHGAP20, AND VARIANT ARG-1288.
RX   PubMed=15543602; DOI=10.1002/gcc.20131;
RA   Kalla C., Nentwich H., Schlotter M., Mertens D., Wildenberger K.,
RA   Doehner H., Stilgenbauer S., Lichter P.;
RT   "Translocation t(X;11)(q13;q23) in B-cell chronic lymphocytic leukemia
RT   disrupts two novel genes.";
RL   Genes Chromosomes Cancer 42:128-143(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-768 (ISOFORM 1).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 623-1802 (ISOFORM 5), AND VARIANT
RP   ARG-1288.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-703 AND SER-1577, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [6]
RP   FUNCTION.
RX   PubMed=21834987; DOI=10.1186/1741-7007-9-54;
RA   Bai S.W., Herrera-Abreu M.T., Rohn J.L., Racine V., Tajadura V.,
RA   Suryavanshi N., Bechtel S., Wiemann S., Baum B., Ridley A.J.;
RT   "Identification and characterization of a set of conserved and new
RT   regulators of cytoskeletal organisation, cell morphology and migration.";
RL   BMC Biol. 9:54-54(2011).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1579, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-693 AND SER-1579, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   VARIANT XLID93 GLU-1596.
RX   PubMed=17668385; DOI=10.1086/520677;
RA   Field M., Tarpey P.S., Smith R., Edkins S., O'Meara S., Stevens C.,
RA   Tofts C., Teague J., Butler A., Dicks E., Barthorpe S., Buck G., Cole J.,
RA   Gray K., Halliday K., Hills K., Jenkinson A., Jones D., Menzies A.,
RA   Mironenko T., Perry J., Raine K., Richardson D., Shepherd R., Small A.,
RA   Varian J., West S., Widaa S., Mallya U., Wooster R., Moon J., Luo Y.,
RA   Hughes H., Shaw M., Friend K.L., Corbett M., Turner G., Partington M.,
RA   Mulley J., Bobrow M., Schwartz C., Stevenson R., Gecz J., Stratton M.R.,
RA   Futreal P.A., Raymond F.L.;
RT   "Mutations in the BRWD3 gene cause X-linked mental retardation associated
RT   with macrocephaly.";
RL   Am. J. Hum. Genet. 81:367-374(2007).
CC   -!- FUNCTION: Plays a role in the regulation of cell morphology and
CC       cytoskeletal organization. Required in the control of cell shape.
CC       {ECO:0000269|PubMed:21834987}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1; Synonyms=BRWD3-A;
CC         IsoId=Q6RI45-1; Sequence=Displayed;
CC       Name=2; Synonyms=BRWD3-B;
CC         IsoId=Q6RI45-2; Sequence=VSP_024305;
CC       Name=3; Synonyms=BRWD3-C, BRWD3-D, BRWD3-E, BRWD3-F, BRWD3-G, BRWD3-L,
CC       BRWD3-M, BRWD3-N, BRWD3-O;
CC         IsoId=Q6RI45-3; Sequence=VSP_024303;
CC       Name=4; Synonyms=BRWD3-H, BRWD3-I, BRWD3-K, BRWD3-P;
CC         IsoId=Q6RI45-4; Sequence=VSP_024304;
CC       Name=5;
CC         IsoId=Q6RI45-5; Sequence=VSP_024306, VSP_024307;
CC   -!- TISSUE SPECIFICITY: Found in most adult tissues. Down-regulated in a
CC       majority of the B-CLL cases examined. {ECO:0000269|PubMed:15543602}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in fetal liver.
CC   -!- DISEASE: Note=A chromosomal aberration involving BRWD3 can be found in
CC       patients with B-cell chronic lymphocytic leukemia (B-CLL).
CC       Translocation t(X;11)(q21;q23) with ARHGAP20 does not result in fusion
CC       transcripts but disrupts both genes.
CC   -!- DISEASE: Intellectual developmental disorder, X-linked 93 (XLID93)
CC       [MIM:300659]: A disorder characterized by significantly below average
CC       general intellectual functioning associated with impairments in
CC       adaptive behavior and manifested during the developmental period.
CC       Intellectual deficiency is the only primary symptom of non-syndromic X-
CC       linked forms, while syndromic forms present with associated physical,
CC       neurological and/or psychiatric manifestations. XLID93 is associated
CC       with macrocephaly. {ECO:0000269|PubMed:17668385}. Note=The disease is
CC       caused by variants affecting the gene represented in this entry.
CC   -!- CAUTION: The translocation involving this gene was originally published
CC       as t(X;11)(q13;23), but BRWD3 is localized to Xq21 and not to Xq13.
CC       {ECO:0000305|PubMed:15543602}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC04641.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="https://atlasgeneticsoncology.org/gene/42978/BRWD3";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY497046; AAS45471.1; -; mRNA.
DR   EMBL; AY497047; AAS45472.1; -; mRNA.
DR   EMBL; AY497048; AAS45473.1; -; mRNA.
DR   EMBL; AY497049; AAS45474.1; -; mRNA.
DR   EMBL; AY497050; AAS45475.1; -; mRNA.
DR   EMBL; AY497051; AAS45476.1; -; mRNA.
DR   EMBL; AY497052; AAS45477.1; -; mRNA.
DR   EMBL; AY497053; AAS45478.1; -; mRNA.
DR   EMBL; AY497054; AAS45479.1; -; mRNA.
DR   EMBL; AY497055; AAS45480.1; -; mRNA.
DR   EMBL; AY497056; AAS45481.1; -; mRNA.
DR   EMBL; AY497057; AAS45482.1; -; mRNA.
DR   EMBL; AY497058; AAS45483.1; -; mRNA.
DR   EMBL; AY497059; AAS45484.1; -; mRNA.
DR   EMBL; AY497060; AAS45485.1; -; mRNA.
DR   EMBL; AL512504; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL590031; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL669934; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC111490; AAI11491.1; -; mRNA.
DR   EMBL; AK095887; BAC04641.1; ALT_INIT; mRNA.
DR   CCDS; CCDS14447.1; -. [Q6RI45-1]
DR   RefSeq; NP_694984.4; NM_153252.4. [Q6RI45-1]
DR   RefSeq; XP_016884873.1; XM_017029384.1. [Q6RI45-3]
DR   AlphaFoldDB; Q6RI45; -.
DR   SMR; Q6RI45; -.
DR   BioGRID; 129012; 44.
DR   IntAct; Q6RI45; 8.
DR   STRING; 9606.ENSP00000362372; -.
DR   ChEMBL; CHEMBL3769296; -.
DR   GlyGen; Q6RI45; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q6RI45; -.
DR   PhosphoSitePlus; Q6RI45; -.
DR   BioMuta; BRWD3; -.
DR   DMDM; 313104082; -.
DR   EPD; Q6RI45; -.
DR   jPOST; Q6RI45; -.
DR   MassIVE; Q6RI45; -.
DR   MaxQB; Q6RI45; -.
DR   PaxDb; Q6RI45; -.
DR   PeptideAtlas; Q6RI45; -.
DR   ProteomicsDB; 67319; -. [Q6RI45-1]
DR   ProteomicsDB; 67320; -. [Q6RI45-2]
DR   ProteomicsDB; 67321; -. [Q6RI45-3]
DR   ProteomicsDB; 67322; -. [Q6RI45-4]
DR   ProteomicsDB; 67323; -. [Q6RI45-5]
DR   Antibodypedia; 537; 54 antibodies from 16 providers.
DR   DNASU; 254065; -.
DR   Ensembl; ENST00000373275.5; ENSP00000362372.4; ENSG00000165288.11. [Q6RI45-1]
DR   GeneID; 254065; -.
DR   KEGG; hsa:254065; -.
DR   MANE-Select; ENST00000373275.5; ENSP00000362372.4; NM_153252.5; NP_694984.5.
DR   UCSC; uc004edt.4; human. [Q6RI45-1]
DR   AGR; HGNC:17342; -.
DR   CTD; 254065; -.
DR   DisGeNET; 254065; -.
DR   GeneCards; BRWD3; -.
DR   HGNC; HGNC:17342; BRWD3.
DR   HPA; ENSG00000165288; Low tissue specificity.
DR   MalaCards; BRWD3; -.
DR   MIM; 300553; gene.
DR   MIM; 300659; phenotype.
DR   neXtProt; NX_Q6RI45; -.
DR   OpenTargets; ENSG00000165288; -.
DR   Orphanet; 323; NON RARE IN EUROPE: FG syndrome phenotypic spectrum.
DR   PharmGKB; PA134900775; -.
DR   VEuPathDB; HostDB:ENSG00000165288; -.
DR   eggNOG; KOG0644; Eukaryota.
DR   GeneTree; ENSGT00950000183107; -.
DR   HOGENOM; CLU_001108_0_0_1; -.
DR   InParanoid; Q6RI45; -.
DR   OMA; TVVTSWK; -.
DR   OrthoDB; 24713at2759; -.
DR   PhylomeDB; Q6RI45; -.
DR   TreeFam; TF324197; -.
DR   PathwayCommons; Q6RI45; -.
DR   SignaLink; Q6RI45; -.
DR   BioGRID-ORCS; 254065; 14 hits in 795 CRISPR screens.
DR   ChiTaRS; BRWD3; human.
DR   GeneWiki; BRWD3; -.
DR   GenomeRNAi; 254065; -.
DR   Pharos; Q6RI45; Tbio.
DR   PRO; PR:Q6RI45; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; Q6RI45; protein.
DR   Bgee; ENSG00000165288; Expressed in tendon of biceps brachii and 170 other tissues.
DR   Genevisible; Q6RI45; HS.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0007010; P:cytoskeleton organization; IMP:UniProtKB.
DR   GO; GO:0008360; P:regulation of cell shape; IMP:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   CDD; cd05529; Bromo_WDR9_I_like; 1.
DR   CDD; cd00200; WD40; 1.
DR   Gene3D; 1.20.920.10; Bromodomain-like; 2.
DR   Gene3D; 2.130.10.10; YVTN repeat-like/Quinoprotein amine dehydrogenase; 3.
DR   InterPro; IPR001487; Bromodomain.
DR   InterPro; IPR036427; Bromodomain-like_sf.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   PANTHER; PTHR16266:SF25; BROMODOMAIN AND WD REPEAT-CONTAINING PROTEIN 3; 1.
DR   PANTHER; PTHR16266; WD REPEAT DOMAIN 9; 1.
DR   Pfam; PF00439; Bromodomain; 2.
DR   Pfam; PF00400; WD40; 5.
DR   PRINTS; PR00503; BROMODOMAIN.
DR   SMART; SM00297; BROMO; 2.
DR   SMART; SM00320; WD40; 8.
DR   SUPFAM; SSF47370; Bromodomain; 2.
DR   SUPFAM; SSF50978; WD40 repeat-like; 1.
DR   PROSITE; PS50014; BROMODOMAIN_2; 2.
DR   PROSITE; PS00678; WD_REPEATS_1; 2.
DR   PROSITE; PS50082; WD_REPEATS_2; 5.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Bromodomain; Chromosomal rearrangement;
KW   Disease variant; Intellectual disability; Phosphoprotein;
KW   Reference proteome; Repeat; WD repeat.
FT   CHAIN           1..1802
FT                   /note="Bromodomain and WD repeat-containing protein 3"
FT                   /id="PRO_0000283089"
FT   REPEAT          170..209
FT                   /note="WD 1"
FT   REPEAT          213..251
FT                   /note="WD 2"
FT   REPEAT          255..297
FT                   /note="WD 3"
FT   REPEAT          307..347
FT                   /note="WD 4"
FT   REPEAT          353..393
FT                   /note="WD 5"
FT   REPEAT          400..452
FT                   /note="WD 6"
FT   REPEAT          456..495
FT                   /note="WD 7"
FT   REPEAT          502..542
FT                   /note="WD 8"
FT   DOMAIN          1158..1228
FT                   /note="Bromo 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00035"
FT   DOMAIN          1317..1412
FT                   /note="Bromo 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00035"
FT   REGION          768..910
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1262..1292
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1326..1361
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1438..1500
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1520..1725
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        800..819
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        842..881
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        882..900
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1338..1361
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1453..1468
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1476..1500
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1521..1535
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1536..1550
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1566..1603
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1604..1626
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1627..1648
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1649..1663
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1680..1694
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         693
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         703
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         885
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:A2AHJ4"
FT   MOD_RES         886
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:A2AHJ4"
FT   MOD_RES         1577
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231"
FT   MOD_RES         1579
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         1763
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:A2AHJ4"
FT   VAR_SEQ         1..404
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15543602"
FT                   /id="VSP_024303"
FT   VAR_SEQ         1..330
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15543602"
FT                   /id="VSP_024304"
FT   VAR_SEQ         1..171
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15543602"
FT                   /id="VSP_024305"
FT   VAR_SEQ         1385..1386
FT                   /note="GS -> DL (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_024306"
FT   VAR_SEQ         1387..1802
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_024307"
FT   VARIANT         1288
FT                   /note="K -> R (in dbSNP:rs3122407)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15543602"
FT                   /id="VAR_031491"
FT   VARIANT         1596
FT                   /note="K -> E (in XLID93; unknown pathological
FT                   significance; dbSNP:rs137853272)"
FT                   /evidence="ECO:0000269|PubMed:17668385"
FT                   /id="VAR_036940"
SQ   SEQUENCE   1802 AA;  203598 MW;  8AA086ABFDCBA2C9 CRC64;
     MAAAPTQIEA ELYYLIARFL QSGPCNKSAQ VLVQELEEHQ LIPRRLDWEG KEHRRSFEDL
     VAANAHIPPD YLLKICERIG PLLDKEIPQS VPGVQTLLGV GRQSLLRDAK DCKSTLWNGS
     AFAALHRGRP PELPVNYVKP PNVVNITSAR QLTGCSRFGH IFPSSAYQHI KMHKRILGHL
     SSVYCVAFDR SGRRIFTGSD DCLVKIWATD DGRLLATLRG HSAEISDMAV NYENTLIAAG
     SCDKVVRVWC LRTCAPVAVL QGHSASITSI QFCPSTKGTN RYLTSTGADG TICFWQWHVK
     TMKFRDRPVK FTERSRPGVQ ISCSSFSSGG MFITTGSTDH VIRIYYLGSE VPEKIAELES
     HTDKVVAVQF CNNGDSLRFV SGSRDGTARI WQYQQQEWKS IVLDMATKMT GNNLPSGEDK
     ITKLKVTMVA WDRYDTTVIT AVNNFLLKVW NSITGQLLHT LSGHDDEVFV LEAHPFDQRI
     ILSAGHDGNI FIWDLDRGTK IRNYFNMIEG QGHGAVFDCK FSPDGNHFAC TDSHGHLLLF
     GFGCSKYYEK IPDQMFFHTD YRPLIRDANN YVLDEQTQQA PHLMPPPFLV DVDGNPHPTK
     FQRLVPGREN CKDEQLIPQL GYVANGDGEV VEQVIGQQTN DQDESILDGI IRELQREQDL
     RLINEGDVPH LPVNRAYSVN GALRSPNMDI SSSPNIRLRR HSSQIEGVRQ MHNNAPRSQM
     ATERDLMAWS RRVVVNELNN GVSRVQEECR TAKGDIEISL YTVEKKKKPS YTTQRNDYEP
     SCGRSLRRTQ RKRQHTYQTR SNIEHNSQAS CQNSGVQEDS DSSSEEDETV GTSDASVEDP
     VVEWQSESSS SDSSSEYSDW TADAGINLQP PKRQTRQTTR KICSSSDEEN LKSLEERQKK
     PKQTRKKKGG LVSIAGEPNE EWFAPQWILD TIPRRSPFVP QMGDELIYFR QGHEAYVRAV
     RKSKIYSVNL QKQPWNKMDL REQEFVKIVG IKYEVGPPTL CCLKLAFLDP ISGKMTGESF
     SIKYHDMPDV IDFLVLHQFY NEAKERNWQI GDRFRSIIDD AWWFGTVESQ QPFQPEYPDS
     SFQCYSVHWD NNEREKMSPW DMEPIPEGTA FPDEVGAGVP VSQEELTALL YKPQEGEWGA
     HSRDEECERV IQGINHLLSL DFASPFAVPV DLSAYPLYCT VVAYPTDLNT IRRRLENRFY
     RRISALMWEV RYIEHNARTF NEPDSPIVKA AKIVTDVLLR FIGDQSCTDI LDTYNKIKAE
     ERNSTDAEED TEIVDLDSDG PGTSSGRKVK CRGRRQSLKC NPDAWKKQCK ELLSLIYERE
     DSEPFRQPAD LLSYPGHQEQ EGESSESVVP ERQQDSSLSE DYQDVIDTPV DFSTVKETLE
     AGNYGSPLEF YKDVRQIFNN SKAYTSNKKS RIYSMMLRLS ALFESHIKNI ISEYKSAIQS
     QKRRRPRYRK RLRSSSSSLS SSGAPSPKGK QKQMKLQPKN DQNTSVSHAR TSSPFSSPVS
     DAAEGLSLYL LDDEPDGPFS SSSFGGYSRS GNSHDPGKAK SFRNRVLPVK QDHSLDGPLT
     NGDGREPRTG IKRKLLSASE EDENMGGEDK EKKETKEKSH LSTSESGELG SSLSSESTCG
     SDSDSESTSR TDQDYVDGDH DYSKFIQTRP KRKLRKQHGN GKRNWKTRGT GGRGRWGRWG
     RWSRGGRGRG GRGRGSRGRG GGGTRGRGRG RGGRGASRGA TRAKRARIAD DEFDTMFSGR
     FSRLPRIKTR NQGRRTVLYN DDSDNDNFVS TEDPLNLGTS RSGRVRKMTE KARVSHLMGW
     NY
//
